Literature DB >> 27604897

Adding tests to risk based guidelines: evaluating improvements in prediction for an intermediate risk group.

Nina P Paynter1, Nancy R Cook2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27604897      PMCID： PMC6884000          DOI： 10.1136/bmj.i4450

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  14 in total

1.  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

2.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

3.  Testing for improvement in prediction model performance.

Authors:  Margaret Sullivan Pepe; Kathleen F Kerr; Gary Longton; Zheyu Wang
Journal:  Stat Med       Date:  2013-01-07       Impact factor: 2.373

4.  Performance of reclassification statistics in comparing risk prediction models.

Authors:  Nancy R Cook; Nina P Paynter
Journal:  Biom J       Date:  2011-02-03       Impact factor: 2.207

5.  Misuse of DeLong test to compare AUCs for nested models.

Authors:  Olga V Demler; Michael J Pencina; Ralph B D'Agostino
Journal:  Stat Med       Date:  2012-03-13       Impact factor: 2.373

6.  A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Authors:  Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

7.  2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

8.  A bias-corrected net reclassification improvement for clinical subgroups.

Authors:  Nina P Paynter; Nancy R Cook
Journal:  Med Decis Making       Date:  2012-10-05       Impact factor: 2.583

9.  Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.

Authors:  Joseph Yeboah; Robyn L McClelland; Tamar S Polonsky; Gregory L Burke; Christopher T Sibley; Daniel O'Leary; Jeffery J Carr; David C Goff; Philip Greenland; David M Herrington
Journal:  JAMA       Date:  2012-08-22       Impact factor: 56.272

10.  Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts.

Authors:  Peter Würtz; Aki S Havulinna; Pasi Soininen; Tuulia Tynkkynen; David Prieto-Merino; Therese Tillin; Anahita Ghorbani; Anna Artati; Qin Wang; Mika Tiainen; Antti J Kangas; Johannes Kettunen; Jari Kaikkonen; Vera Mikkilä; Antti Jula; Mika Kähönen; Terho Lehtimäki; Debbie A Lawlor; Tom R Gaunt; Alun D Hughes; Naveed Sattar; Thomas Illig; Jerzy Adamski; Thomas J Wang; Markus Perola; Samuli Ripatti; Ramachandran S Vasan; Olli T Raitakari; Robert E Gerszten; Juan-Pablo Casas; Nish Chaturvedi; Mika Ala-Korpela; Veikko Salomaa
Journal:  Circulation       Date:  2015-01-08       Impact factor: 29.690
View more
  5 in total

1.  Estimating the receiver operating characteristic curve in matched case control studies.

Authors:  Hui Xu; Jing Qian; Nina P Paynter; Xuehong Zhang; Brian W Whitcomb; Shelley S Tworoger; Kathryn M Rexrode; Susan E Hankinson; Raji Balasubramanian
Journal:  Stat Med       Date:  2018-11-22       Impact factor: 2.373

2.  Lipoprotein(a) and Cardiovascular Risk Prediction Among Women.

Authors:  Nancy R Cook; Samia Mora; Paul M Ridker
Journal:  J Am Coll Cardiol       Date:  2018-07-09       Impact factor: 24.094

3.  Assessing the Accuracy of a Deep Learning Method to Risk Stratify Indeterminate Pulmonary Nodules.

Authors:  Pierre P Massion; Sanja Antic; Sarim Ather; Carlos Arteta; Jan Brabec; Heidi Chen; Jerome Declerck; David Dufek; William Hickes; Timor Kadir; Jonas Kunst; Bennett A Landman; Reginald F Munden; Petr Novotny; Heiko Peschl; Lyndsey C Pickup; Catarina Santos; Gary T Smith; Ambika Talwar; Fergus Gleeson
Journal:  Am J Respir Crit Care Med       Date:  2020-07-15       Impact factor: 21.405

4.  Quantifying the added value of new biomarkers: how and how not.

Authors:  Nancy R Cook
Journal:  Diagn Progn Res       Date:  2018-07-11

Review 5.  Noninvasive biomarkers for lung cancer diagnosis, where do we stand?

Authors:  Michael N Kammer; Pierre P Massion
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 3.005
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.